>
Switch to:

Corcept Therapeutics Price-to-Free-Cash-Flow

: 20.95 (As of Today)
View and export this data going back to 2004. Start your Free Trial

As of today (2021-03-01), Corcept Therapeutics's share price is $25.460000. Corcept Therapeutics's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2020 was $1.22. Hence, Corcept Therapeutics's Price-to-Free-Cash-Flow Ratio for today is 20.95.

NAS:CORT' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 8.67   Med: 23.13   Max: 195.93
Current: 20.97
8.67
195.93

During the past 13 years, Corcept Therapeutics's highest Price-to-Free-Cash-Flow Ratio was 195.93. The lowest was 8.67. And the median was 23.13.

NAS:CORT's Price-to-Free-Cash-Flow is ranked higher than
74% of the 212 Companies
in the Biotechnology industry.

( Industry Median: 47.27 vs. NAS:CORT: 20.97 )

Corcept Therapeutics's Free Cash Flow per Share for the three months ended in Dec. 2020 was $0.27. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $1.22.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of Corcept Therapeutics was 10.20% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 35.70% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 105.10% per year.

During the past 13 years, Corcept Therapeutics's highest 3-Year average Free Cash Flow per Share Growth Rate was 215.50% per year. The lowest was -4.60% per year. And the median was 18.85% per year.

Corcept Therapeutics Price-to-Free-Cash-Flow Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Corcept Therapeutics Annual Data
Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Price-to-Free-Cash-Flow Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45.95 37.39 14.67 10.99 21.53

Corcept Therapeutics Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
Price-to-Free-Cash-Flow Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.99 10.04 11.94 13.04 21.53
Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.

Corcept Therapeutics Price-to-Free-Cash-Flow Distribution

* The bar in red indicates where Corcept Therapeutics's Price-to-Free-Cash-Flow falls into.


Corcept Therapeutics Price-to-Free-Cash-Flow Calculation

Corcept Therapeutics's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=25.460000/1.215
=20.95

Corcept Therapeutics's Share Price of today is $25.460000.
Corcept Therapeutics's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2020 was 0.272 (Mar. 2020 ) + 0.431 (Jun. 2020 ) + 0.239 (Sep. 2020 ) + 0.273 (Dec. 2020 ) = $1.22.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Corcept Therapeutics  (NAS:CORT) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.

Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.

Corcept Therapeutics Price-to-Free-Cash-Flow Related Terms

Corcept Therapeutics Price-to-Free-Cash-Flow Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)